Mechanisms involved in enhancement of plasma fibrinolytic activity by chloroform
- PMID: 135588
Mechanisms involved in enhancement of plasma fibrinolytic activity by chloroform
Abstract
The effects of a single 1-min extraction with chloroform (CHCl3) on plasma fibrinolytic activity has been examined by 125I-fibrin solid phase assay, using normal plasma and plasma depleted of plasminogen (PLG) by lysine-Sepharose affinity chromatography. Fibrinolytic activity of normal plasma is increased (40%-175%), and more than 95% of antiplasmin activity is removed. The increase is demonstrable in PLG-depleted plasma, and is not inhibited by tranexamic acid (0.01 M). Purified PLG is not activated to plasmin by ChCl3 treatment. Bio-Gel A 0.5 m fractionation of CHCl3-extracted, PLG-depleted plasma reveals fractions with the following activities: (1) streptokinase-activatable, PLG-independent fibrinolytic activities; (2) PLG activator activities; and (3) plasmin-stimulated but PLG-independent fibrinolytic activities, which include activities inhibited by hexadimethrine bromide and which cofractionate in part with plasmin-stimulated procoagulant activities. In addition, similar fractionation of nonextracted plasma reveals two non-plasmin fibrinolytic activities (approximately 30,000 and 13,000 daltons) activated by streptokinase and plasmin, respectively. The findings indicate that the enhanced fibrinolytic activity resulting from CHCl3 treatment is independent of plasmin as the ultimate fibrinolytic enzyme, although activities stimulated by plasmin may contribute, and that such treatment is a useful maneuver for study of PLG-dependent and PLG-independent fibrinolytic mechanisms, and their interactions.
Similar articles
-
Fibrinolysis in normal plasma and blood: evidence for significant mechanisms independent of the plasminogen-plasmin system.Blood. 1976 Oct;48(4):531-45. Blood. 1976. PMID: 134751
-
Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.J Trauma Acute Care Surg. 2019 Jan;86(1):101-107. doi: 10.1097/TA.0000000000002092. J Trauma Acute Care Surg. 2019. PMID: 30575685
-
Mafenide (Sulfamylon) inhibits plasmin fibrinolytic activity.Thromb Haemost. 1988 Jun 16;59(3):440-4. Thromb Haemost. 1988. PMID: 2973151
-
The fibrinolytic system in man.Crit Rev Oncol Hematol. 1986;4(3):249-301. doi: 10.1016/s1040-8428(86)80014-2. Crit Rev Oncol Hematol. 1986. PMID: 2420482 Review.
-
Physiology of plasminogen: with special reference to activation and degradation.Haemostasis. 1988;18 Suppl 1:25-35. doi: 10.1159/000215834. Haemostasis. 1988. PMID: 3280423 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous